Cem Gabay
Serious infection risk of tofacitinib compared to biologics in patients with rheumatoid arthritis treated in routine clinical care.
Riek M, Scherer A, Möller B, Ciurea A, Von Mühlenen I, Gabay C, Kyburz D, Brulhart L, von Kempis J, Mueller R, Hasler P, Strahm T, von Känel S, Zufferey P, Dudler J, Finckh A. Serious infection risk of tofacitinib compared to biologics in patients with rheumatoid arthritis treated in routine clinical care. Sci Rep 2023; 13:17776.
18.10.2023Serious infection risk of tofacitinib compared to biologics in patients with rheumatoid arthritis treated in routine clinical care.
18.10.2023Sci Rep 2023; 13:17776
Riek Myriam, Scherer Almut, Möller Burkhard, Ciurea Adrian, Von Mühlenen Ines, Gabay Cem, Kyburz Diego, Brulhart Laure, von Kempis Johannes, Mueller Ruediger B, Hasler Paul, Strahm Tanja, von Känel Sabine, Zufferey Pascal, Dudler Jean, Finckh Axel
Consensus statement on blocking interleukin-6 receptor and interleukin-6 in inflammatory conditions: an update.
Aletaha D, Kerschbaumer A, Kastrati K, Dejaco C, Dougados M, McInnes I, Sattar N, Stamm T, Takeuchi T, Trauner M, van der Heijde D, Voshaar M, Winthrop K, Ravelli A, Betteridge N, Burmester G, Bijlsma J, Bykerk V, Caporali R, Choy E, Codreanu C, Combe B, Crow M, de Wit M, Emery P, Fleischmann R, Gabay C, Hetland M, Hyrich K, Iagnocco A, Isaacs J, Kremer J, Mariette X, Merkel P, Mysler E, Nash P, Nurmohamed M, Pavelka K, Poór G, Rubbert-Roth A, Schulze-Koops H, Strangfeld A, Tanaka Y, Smolen J. Consensus statement on blocking interleukin-6 receptor and interleukin-6 in inflammatory conditions: an update. Ann Rheum Dis 2022
11.08.2022Consensus statement on blocking interleukin-6 receptor and interleukin-6 in inflammatory conditions: an update.
11.08.2022Ann Rheum Dis 2022
Aletaha Daniel, Kerschbaumer Andreas, Kastrati Kastriot, Dejaco Christian, Dougados Maxime, McInnes Iain B, Sattar Naveed, Stamm Tanja, Takeuchi Tsutomu, Trauner Michael, van der Heijde Désirée, Voshaar Marieke, Winthrop Kevin, Ravelli Angelo, Betteridge Neil, Burmester Gerd-Rüdiger, Bijlsma Johannes Wj, Bykerk Vivian, Caporali Roberto, Choy Ernest H S, Codreanu Catalin, Combe Bernard, Crow Mary K, de Wit Maarten, Emery Paul, Fleischmann Roy, Gabay Cem, Hetland Merete Lund, Hyrich Kimme L, Iagnocco Annamaria, Isaacs John D, Kremer Joel M, Mariette Xavier, Merkel Peter A, Mysler Eduardo F, Nash Peter, Nurmohamed Michael T, Pavelka Karel, Poór Gyula, Rubbert-Roth Andrea, Schulze-Koops Hendrik, Strangfeld Anja, Tanaka Yoshiya, Smolen Josef S
Evolving the comprehensive management of rheumatoid arthritis: identification of unmet needs and development of practical and educational tools
Burmester G, Taylor P, Szekanecz Z, Stamm T, Rubbert-Roth A, Ramiro S, Østergaard M, Montecucco C, Iagnocco A, Gabay C, Ferreira R, Fautrel B, Durez P, Combe B, Calvo Alén J, Betteridge N, Álvaro-Gracia J, van de Laar M. Evolving the comprehensive management of rheumatoid arthritis: identification of unmet needs and development of practical and educational tools. Clin Exp Rheumatol 2020; 38:1056-1067.
17.11.2020Evolving the comprehensive management of rheumatoid arthritis: identification of unmet needs and development of practical and educational tools
17.11.2020Clin Exp Rheumatol 2020; 38:1056-1067
Burmester Gerd-Rüdiger, Taylor Peter C, Szekanecz Zoltán, Stamm Tanja, Rubbert-Roth Andrea, Ramiro Sofia, Østergaard Mikkel, Montecucco Carlomaurizio, Iagnocco Annamaria, Gabay Cem, Ferreira Ricardo J O, Fautrel Bruno, Durez Patrick, Combe Bernard, Calvo Alén Jaime, Betteridge Neil, Álvaro-Gracia José María, van de Laar Mart
Female hormonal factors and the development of anti-citrullinated protein antibodies in women at risk of rheumatoid arthritis
Alpizar-Rodriguez D, Gabay C, Courvoisier D, Lamacchia C, Mahler M, Roux-Lombard P, Von Mühlenen I, Walker U, Kyburz D, Zufferey P, Ciurea A, Dudler J, Möller B, Müller R, Finckh A. Female hormonal factors and the development of anti-citrullinated protein antibodies in women at risk of rheumatoid arthritis. Rheumatology (Oxford) 2017; 56:1579-1585.
01.09.2017Female hormonal factors and the development of anti-citrullinated protein antibodies in women at risk of rheumatoid arthritis
01.09.2017Rheumatology (Oxford) 2017; 56:1579-1585
Alpizar-Rodriguez Deshiré, Gabay Cem, Courvoisier Delphine S, Lamacchia Céline, Mahler Michael, Roux-Lombard Pascale, Von Mühlenen Ines, Walker Ulrich A, Kyburz Diego, Zufferey Pascal, Ciurea Adrian, Dudler Jean, Möller Burkhard, Müller Rüdiger, Finckh Axel
Presence of IL-17 in synovial fluid identifies a potential inflammatory osteoarthritic phenotype
Snelling S, Carr A, Hoffmeyer P, Gabay C, Finckh A, Suva D, Dakin S, Puskas G, Bas S, Lübbeke A. Presence of IL-17 in synovial fluid identifies a potential inflammatory osteoarthritic phenotype. PloS one 2017; 12:e0175109.
11.04.2017Presence of IL-17 in synovial fluid identifies a potential inflammatory osteoarthritic phenotype
11.04.2017PloS one 2017; 12:e0175109
Snelling Sarah J B, Carr Andrew J, Hoffmeyer Pierre, Gabay Cem, Finckh Axel, Suva Domizio, Dakin Stephanie G, Puskas Gabor, Bas Sylvette, Lübbeke Anne
The prevalence of anticitrullinated protein antibodies increases with age in healthy individuals at risk for rheumatoid arthritis
Alpizar-Rodriguez D, Bas S, Gascon D, Lamacchia C, Roux-Lombard P, Lauper K, Nissen M, Courvoisier D, Gabay C, Mahler M, Zufferey P, Brulhart L, Müller R, Möller B, Dudler J, Ciurea A, Walker U, Von Mühlenen I, Kyburz D, Finckh A. The prevalence of anticitrullinated protein antibodies increases with age in healthy individuals at risk for rheumatoid arthritis. Clin Rheumatol 2017
21.01.2017The prevalence of anticitrullinated protein antibodies increases with age in healthy individuals at risk for rheumatoid arthritis
21.01.2017Clin Rheumatol 2017
Alpizar-Rodriguez D, Bas Sylvette, Gascon Danielle, Lamacchia Céline, Roux-Lombard Pascale, Lauper Kim, Nissen Michael J, Courvoisier Delphine S, Gabay Cem, Mahler Michael, Zufferey Pascal, Brulhart Laure, Müller Rüdiger, Möller Burkhard, Dudler Jean, Ciurea Adrian, Walker Ulrich A, Von Mühlenen Ines, Kyburz Diego, Finckh Axel
The dermatologists' role in managing psoriatic arthritis: results of a Swiss Delphi exercise intended to improve collaboration with rheumatologists
Boehncke W, Yawalkar N, Villiger P, Navarini A, Möller B, Michel B, Laffitte E, Kyburz D, Häusermann P, Hasler P, Hasler F, Dudler J, Conrad C, Anliker M, Gabay C. The dermatologists' role in managing psoriatic arthritis: results of a Swiss Delphi exercise intended to improve collaboration with rheumatologists. Dermatology (Basel) 2015; 230:75-81.
06.01.2015The dermatologists' role in managing psoriatic arthritis: results of a Swiss Delphi exercise intended to improve collaboration with rheumatologists
06.01.2015Dermatology (Basel) 2015; 230:75-81
Boehncke Wolf-Henning, Yawalkar Nikhil, Villiger Peter M, Navarini Alexander A, Möller Burkhard, Michel Beat A, Laffitte Emmanuel, Kyburz Diego, Häusermann Peter, Hasler Paul, Hasler Fritz, Dudler Jean, Conrad Curdin, Anliker Mark, Gabay Cem
Adipokines correlate with pain in lower limb osteoarthritis: different associations in hip and knee
Bas S, Finckh A, Puskas G, Suva D, Hoffmeyer P, Gabay C, Lübbeke A. Adipokines correlate with pain in lower limb osteoarthritis: different associations in hip and knee. Int Orthop 2014; 38:2577-83.
09.07.2014Adipokines correlate with pain in lower limb osteoarthritis: different associations in hip and knee
09.07.2014Int Orthop 2014; 38:2577-83
Bas Sylvette, Finckh Axel, Puskas Gabor, Suva Domizio, Hoffmeyer Pierre, Gabay Cem, Lübbeke Anne
The advent of biosimilars: challenges and risks
Müller R, Renner C, Gabay C, Cassata G, Lohri A, Hasler P. The advent of biosimilars: challenges and risks. Swiss Med Wkly 2014; 144:w13980.
01.07.2014The advent of biosimilars: challenges and risks
01.07.2014Swiss Med Wkly 2014; 144:w13980
Müller Rüdiger, Renner Christoph, Gabay Cem, Cassata Giuseppe, Lohri Andreas, Hasler Paul